Search results for: 'sinc cancer partnering 2016 2025'

Did you mean: scienc cancer partnering 2016 2025

Related search terms: partnering agreements with regen pharmaceutical 2025 2016; partnering agreements with regeneron pharmaceutical 2020 2025; partnering agreements with csl 2025 2020; partnering agreements where actavis formerly watson pharmaceutical 2025 2025; partnering agreements while actavis formerly watson pharmaceutical 2025 2025

Sepsis Diagnostics: Market Forecasts by Assay, Cause, Product, Place and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Sepsis Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Molecular Diagnostics for Infectious Disease: Market Forecasts by Syndrome, Plex, Place and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Infectious Disease Molecular Diagnostics (MDx) Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Royalty Rates in Pharmaceutical and Biotechnology Deals 2015 to 2026
March 2026

$4,995.00

Add to Wish List Add to Compare

Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2026 | 11+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More
Licensing Deals in Pharmaceuticals 2020-2026
March 2026

$4,995.00

Add to Wish List Add to Compare

Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2026
March 2026

$3,995.00

Add to Wish List Add to Compare

Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026
March 2026

$3,995.00

Add to Wish List Add to Compare

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026
Learn More
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026
March 2026

$3,995.00

Add to Wish List Add to Compare

Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More
Infectious Disease Collaboration and Licensing Deals 2019-2026
April 2026

$4,995.00

Add to Wish List Add to Compare

Infectious Disease Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2026
Learn More
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2026
March 2026

$3,995.00

Add to Wish List Add to Compare

Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More